{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:48:52Z","timestamp":1770511732479,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ijpharm.2014.04.044","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T21:16:16Z","timestamp":1397855776000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: Preparation, in vitro and in vivo evaluation"],"prefix":"10.1016","volume":"469","author":[{"given":"Che","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Lihong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Qiuyuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Hongzhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.04.044_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.drudis.2013.01.013","article-title":"Injectable implants for the sustained release of protein and peptide drugs","volume":"18","author":"Agarwal","year":"2013","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2012.11.014","article-title":"In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer","volume":"165","author":"Asmus","year":"2013","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jps.21415","article-title":"Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior","volume":"98","author":"Astaneh","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0142-9612(96)85754-1","article-title":"Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid\/polyglycolic acid copolymers","volume":"17","author":"Athanasiou","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/pat.717","article-title":"The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant","volume":"17","author":"Bakhshi","year":"2006","journal-title":"Polymers for Advanced Technologies"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0030","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1023\/A:1018943107688","article-title":"Sustained release of human growth hormone from PLGA solution depots","volume":"16","author":"Brodbeck","year":"1999","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejpb.2010.08.002","article-title":"Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions","volume":"76","author":"Burckbuchler","year":"2010","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/03639045.2012.660952","article-title":"Injectable PLA-based in situ forming implants for controlled release of ivermectin a BCS Class II drug: solvents election based on physico-chemical characterization","volume":"39","author":"Camargo","year":"2013","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2005.02.023","article-title":"Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation","volume":"295","author":"Chen","year":"2005","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2007.04.034","article-title":"Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system","volume":"342","author":"Chhabra","year":"2007","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0055","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1039\/c1sm05310h","article-title":"An in situ-forming, solid lipid\/PLGA hybrid implant for long-acting antipsychotics","volume":"7","author":"Dong","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0060","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1023\/A:1007621512647","article-title":"Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo","volume":"17","author":"Eliaz","year":"2000","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0926-6690(99)00009-6","article-title":"Rheological properties of amorphous and semicrystalline polylactic acid polymers","volume":"10","author":"Fang","year":"1999","journal-title":"Industrial Crops and Products"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0928-0987(02)00023-4","article-title":"PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release","volume":"15","author":"Faisant","year":"2002","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187221109787158300","article-title":"Smart polymers for controlled delivery of proteins and peptides: a review of patents","volume":"3","author":"Fogueri","year":"2009","journal-title":"Recent Patents on Drug Delivery and Formulation"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolicacid)-based drug delivery systems a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1208\/s12249-008-9126-9","article-title":"Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and\/or doxycycline for treatment of periodontitis","volume":"9","author":"Gad","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0142-9612(96)85755-3","article-title":"Mechanisms of polymer degradation and erosion","volume":"17","author":"G\u00f6pferich","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-3659(02)00008-1","article-title":"Biodegradable injectable in situ forming drug delivery systems","volume":"80","author":"Hate","year":"2002","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0939-6411(00)00062-X","article-title":"Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables","volume":"50","author":"Jain","year":"2000","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-3659(99)00194-7","article-title":"Drug release from biodegradable injectable thermosensitive hydrogel of PEG\u2013PLGA\u2013PEG triblock copolymers","volume":"63","author":"Jeong","year":"2000","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2005.07.024","article-title":"In vitro release of insulin and biocompatibility of in situ forming gel systems","volume":"304","author":"Kang","year":"2005","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2012.01.005","article-title":"In situ forming implant for controlled delivery of an anti-HIV fusion inhibitor","volume":"426","author":"Kapoor","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1081\/DDC-100103737","article-title":"Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats","volume":"27","author":"Kazuhiro","year":"2001","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/DDC-100102137","article-title":"In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease","volume":"25","author":"Kelly","year":"1999","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2012.04.016","article-title":"In situ forming implants \u2013 an attractive formulation principle for parenteral depot formulations","volume":"161","author":"Kempe","year":"2012","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2006.09.033","article-title":"A novel in situ forming drug delivery system for controlled parenteral drug delivery","volume":"332","author":"Kranz","year":"2007","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-5173(00)00568-8","article-title":"Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems","volume":"212","author":"Kranz","year":"2001","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0145","first-page":"1347","article-title":"In vitro and in vivo drug release from a novel in situ forming drug delivery system","volume":"25","author":"Kranz","year":"2008","journal-title":"Pharmceutical Reseasrch"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.07.015","article-title":"In vitro and in vivo study of thymosin alphal biodegradable in situ forming poly(lactide-co-glycolide) implants","volume":"397","author":"Liu","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2005.10.005","article-title":"Influence of the poly (lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems","volume":"110","author":"Luan","year":"2006","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0160","first-page":"103","article-title":"Biodegradable injectable implants systems for sustained delivery using poly(lactide-co-glycolide) copolymers","author":"Madhu","year":"2009","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0165","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/17425247.2012.709844","article-title":"Recent advances in polymeric microspheres for parenteral drug delivery \u2013 Part 1","volume":"9","author":"Mao","year":"2012","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00289-010-0386-7","article-title":"The effect of aliphatic esters on the formation and degradation behavior of PLGA-based in situ forming system","volume":"66","author":"Mashak","year":"2011","journal-title":"Polymer Bulletin"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2004.03.003","article-title":"In situ forming parenteral drug delivery systems: an over view","volume":"58","author":"Packhaeuser","year":"2004","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jconrel.2010.08.020","article-title":"Effect of injection site on in situ implant formation and drug release in vivo","volume":"147","author":"Patel","year":"2010","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10717540590968873","article-title":"Effect of co-solvents on the controlled release of calciton in polypeptide from in situ biodegradable polymer implants","volume":"12","author":"Prabhu","year":"2005","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0190","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/jbm.b.32788","article-title":"Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitis","volume":"100","author":"Qin","year":"2012","journal-title":"Journal of Biomedical Materials Research Part B: Applied Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/156720109787846243","article-title":"Influence of poly(lactide-co-glycolide) type and gamma irradiation on the betamethasone acetate release from the in situ forming systems","volume":"6","author":"Raenia","year":"2009","journal-title":"Current Drug Delivery"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5173(99)00371-3","article-title":"Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide","volume":"194","author":"Ravivarapu","year":"2000","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H","article-title":"Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys","volume":"45","author":"Royals","year":"1999","journal-title":"Journal of Biomedical Materials Research"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0210","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejps.2008.12.003","article-title":"Injectability of biodegradable in situ forming microparticle systems (ISM)","volume":"36","author":"Rungseevijitprapa","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2007.10.009","article-title":"Myotoxicity studies of O\/W-in situ forming microparticle systems","volume":"69","author":"Rungseevijitprapa","year":"2008","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0220","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1002\/jps.22149","article-title":"Biocompatibility of an injectable in situ forming depot for peptide delivery","volume":"99","author":"Schoenhammer","year":"2010","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.01.053","article-title":"Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems","volume":"357","author":"Tang","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0230","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0142-9612(99)00002-2","article-title":"Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro","volume":"20","author":"Tracy","year":"1999","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0235","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijpharm.2012.02.015","article-title":"Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism","volume":"427","author":"Wang","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0240","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/chir.20453","article-title":"Stereoselective behavior of a novel biodegradable racemic ketoprofen injectable implantinrats","volume":"19","author":"Wang","year":"2007","journal-title":"Chirality"},{"key":"10.1016\/j.ijpharm.2014.04.044_bib0245","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s11095-010-0202-y","article-title":"Development of PLGA-based injectable delivery systems for hydrophobic fenretinide","volume":"27","author":"Wischke","year":"2010","journal-title":"Pharmaceutical Research"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T20:25:51Z","timestamp":1538684751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0378517314002804"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.04.044","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: Preparation, in vitro and in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}